Clinical classification of pulmonary hypertension.
暂无分享,去创建一个
W. Seeger | R. Speich | S. Rich | A. Fishman | G. Simonneau | L. Rubin | D. Langleben | M. Beghetti | D. Lebrec | S. Gibbs | G. Domenighetti | N. Galiè
[1] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[2] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[3] W. Seeger,et al. Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial , 2000, Annals of Internal Medicine.
[4] Stuart Rich,et al. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.
[5] M. Keszler,et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. , 2000, The New England journal of medicine.
[6] E. Trulock,et al. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. , 2000, Clinical transplants.
[7] G. Patterson,et al. Lung transplantation: a decade of experience. , 1999, Annals of surgery.
[8] M. Humbert,et al. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study , 1999 .
[9] N. Voelkel,et al. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. , 1999, The Journal of clinical investigation.
[10] S. Rich,et al. Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series , 1999, Annals of Internal Medicine.
[11] R. Barst,et al. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. , 1999, Circulation.
[12] R. Whyte,et al. Heart-lung transplantation for primary pulmonary hypertension. , 1999, The Annals of thoracic surgery.
[13] G. Maislin,et al. Vasodilator therapy for primary pulmonary hypertension in children. , 1999, Circulation.
[14] K. Stenmark,et al. Treatments for severe pulmonary hypertension , 1999, The Lancet.
[15] A. Fishman. Aminorex to fen/phen: an epidemic foretold. , 1999, Circulation.
[16] M. Humbert,et al. High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease. , 1998, AJR. American journal of roentgenology.
[17] M. Humbert,et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. , 1998, The European respiratory journal.
[18] L. Sharples,et al. Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension , 1998, Heart.
[19] J. Sandoval,et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. , 1998, Journal of the American College of Cardiology.
[20] M. Humbert,et al. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). , 1998, Chest.
[21] M. Humbert,et al. Pulmonary vascular disorders in portal hypertension. , 1998, The European respiratory journal.
[22] M. Humbert,et al. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. , 1998, American journal of respiratory and critical care medicine.
[23] T. Higenbottam,et al. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost , 1998, Heart.
[24] S. Rich,et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. , 1998, The New England journal of medicine.
[25] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[26] H. Stricker,et al. Prostacyclin for HIV-Associated Pulmonary Hypertension , 1997, Annals of Internal Medicine.
[27] S. Hodge,et al. Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. , 1997, Circulation.
[28] C. Howell,et al. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. , 1997, Transplantation.
[29] S. Swensen,et al. Pulmonary venoocclusive disease: CT findings in eight patients. , 1996, AJR. American journal of roentgenology.
[30] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[31] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[32] W. Summer,et al. Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease. , 1995, Chest.
[33] P. Dartevelle,et al. [Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]. , 1994, Archives des maladies du coeur et des vaisseaux.
[34] R. Barst,et al. Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin , 1994, Annals of Internal Medicine.
[35] M. Dolgin,et al. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .
[36] H. Winer-Muram,et al. Pulmonary capillary hemangiomatosis: a clinicopathologic review. , 1994, The Annals of thoracic surgery.
[37] G. Pietra. Histopathology of primary pulmonary hypertension. , 1994, Chest.
[38] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[39] W. Auger,et al. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. , 1992, The European respiratory journal.
[40] T. Higenbottam,et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension , 1991, The Lancet.
[41] D. Greenberg. THE PULMONARY CIRCULATION: NORMAL AND ABNORMAL , 1991 .
[42] W. Edwards. Plexogenic pulmonary arteriopathy , 1990, Histopathology.
[43] J. H. Diehl,et al. Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial , 1990 .
[44] S. Hunt,et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. , 1982, The New England journal of medicine.
[45] K. Peterson,et al. Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. , 1987, The Journal of thoracic and cardiovascular surgery.
[46] E. Shinebourne,et al. Effect of long term oxygen treatment at home in children with pulmonary vascular disease. , 1986, British heart journal.
[47] E. Weitzenblum,et al. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.
[48] F. Khaja,et al. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. , 1985, Annals of internal medicine.
[49] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[50] T. Higenbottam,et al. LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN) , 1984, The Lancet.
[51] B. Groves,et al. Prostacyclin‐induced Acute Pulmonary Vasodilation in Primary Pulmonary Hypertension , 1982, Circulation.
[52] W. Edwards,et al. Clinical primary pulmonary hypertension: three pathologic types. , 1977, Circulation.
[53] J. Shaver,et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). , 1977, Annals of internal medicine.
[54] A. Fishman. Dietary Pulmonary Hypertension , 1974, Circulation research.
[55] E. Dailey,et al. Pulmonary thromboembolic disease. A lobular concept. , 1972, Radiology.
[56] J. Edwards,et al. The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.
[57] John Rose Bradford,et al. The Pulmonary Circulation 1 , 1894 .
[58] W. Ingalls. A Case of Fracture of the Spleen, and Rupture of the Intestines, Occasioned by External Violence , 1828 .